Michaela B. E.
- Country
- Austria
- Department
- Department of Clinical Pharmacology
Research Overview
- Evaluation of Topical Glyceryl Trinitrate on Genitourinary Syndrome of Menopause and Female Sexual Dysfunction in Peri- and Postmenopausal Women: A Pilot Study
- Evaluation of AZD9550 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Overweight and Obese Patients with Non-alcoholic Steatohepatitis
Data & Insights
Has run more than one trial at 1 of 6 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in the management of non-alcoholic steatohepatitis (NASH) and its relationship with obesity and metabolic conditions. Their work encompasses therapeutic approaches for patients with varying metabolic profiles, including those with Type 2 diabetes mellitus.
- Obesity Management
- NASH Treatment
- Metabolic Health
Their research integrates novel therapeutic approaches for weight management in overweight and obese populations.
Women's Health
The investigator focuses on addressing genitourinary syndrome of menopause and its associated complications. Their expertise extends to the treatment of female sexual dysfunction during the perimenopausal and postmenopausal periods.
- Menopausal Care
- Sexual Health
- Genitourinary Medicine
Their work explores innovative topical treatments for improving genital function in menopausal women.
Clinical Pharmacology
The investigator studies the pharmacokinetics and pharmacodynamics of novel therapeutic agents. Their expertise includes evaluating drug safety profiles and determining optimal dosing strategies for various patient populations.
- Drug Safety Assessment
- Dose Optimization
- Therapeutic Monitoring
Their research involves systematic evaluation of drug tolerability across different therapeutic contexts.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.